收稿日期: 2025-03-17
修回日期: 2025-08-27
网络出版日期: 2025-12-25
基金资助
上海市科学技术委员会课题(21Y31920400);上海市杨浦区中心医院院级课题资助(Se1202415)
Analysis of diagnosis and treatment of 9 cases of primary thyroid lymphoma
Received date: 2025-03-17
Revised date: 2025-08-27
Online published: 2025-12-25
目的: 分析总结原发性甲状腺淋巴瘤(primary thyroid lymphoma,PTL)患者的临床及超声影像学特征、诊断及治疗经验。方法: 2022年10月至2024年12月期间,收集上海交通大学医学院附属第六人民医院收治的经病理活检证实为PTL的9例连续病例,回顾性分析其临床资料、超声特征、病理诊断方式及诊治经过。结果: 9例患者中,女性7例,男性2例,中位年龄76岁(39~88岁)。所有患者均因颈部进行性增大肿块就诊,6例伴梗阻症状,8例合并桥本甲状腺炎(Hashimoto’s thyroiditis, HT)。超声分型为弥漫型2例(受累叶弥漫性增大,呈现低回声伴内部线状回声,后方回声增强),结节型3例(单发低回声结节),混合型4例(腺体肿大,伴多发低回声区)。病理诊断方式中,5例经细针穿刺抽吸(fine needle aspiration, FNA)联合空芯针活检(core needle biopsy, CNB)确诊;2例经CNB直接确诊;2例经手术病理确诊。所有患者初始均接受免疫化疗(R-CHOP/miniCHOP或Pola-R-miniCHP±Glofit,6~8个疗程),3例未达完全缓解者后续联合受累区域放疗。7例可评估患者中,完全缓解4例,部分缓解2例,1例部分缓解后进展死亡。结论: 老年HT患者出现短期内甲状腺肿块迅速增大伴梗阻症状时,需警惕PTL。PTL特征性超声表现为弥漫性和(或)结节性的低或极低回声病灶,伴内部线状高回声、后方回声增强、丰富血流及无钙化。临床疑诊PTL时,推荐优先采用CNB细胞学检查,以提高诊断准确率。以免疫化疗为主,或联合放疗的综合治疗,可获良好预后。
陆弘逾 , 徐又海 , 许浩 , 刘丹 , 宋陆茜 . 9例原发性甲状腺淋巴瘤的诊治分析[J]. 诊断学理论与实践, 2025 , 24(06) : 634 -640 . DOI: 10.16150/j.1671-2870.2025.06.009
Objective To analyze and summarize the clinical and ultrasonographic features, as well as the diagnostic and therapeutic experiences, of patients with primary thyroid lymphoma (PTL). Methods A total of 9 consecutive cases of PTL, confirmed by pathological biopsy and admitted to Shanghai Sixth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine from October 2022 to December 2024, were collected. A retrospective analysis was conducted on their clinical data, ultrasonographic characteristics, pathological diagnostic methods, and diagnosis and treatment process. Results Among the 9 patients (7 females, 2 males), the median age was 76 years (range: 39-88 years). All patients presented with progressively enlarging neck masses, six cases had obstructive symptoms, and eight cases were complicated with Hashimoto's thyroiditis (HT). Ultrasonography classified cases as: diffuse type (n=2, diffusely enlarged involved lobe with hypoechogenicity, internal linear echoes, and posterior acoustic enhancement), nodular type (n=3, solitary hypoechoic nodules), and mixed type (n=4, glandular enlargement with multifocal hypoechoic lesions). Regarding pathological diagnosis methods, 5 cases were confirmed by fine needle aspiration (FNA) combined with core needle biopsy (CNB), 2 cases were directly diagnosed by CNB, and 2 cases were diagnosed by surgical pathology. All patients initially received immunochemotherapy (R-CHOP/miniCHOP or Pola-R-miniCHP ± Glofit, 6-8 cycles). Three patients with incomplete remission received subsequent involved-site radiotherapy. Among 7 evaluable patients, 4 achieved complete remission (CR), 2 had partial remission (PR), and 1 died of progression after PR. Conclusions When elderly HT patients pre-sent with rapidly enlarged thyroid mass and obstructive symptoms over a short period, the possibility of PTL should be suspected. Characteristic ultrasonographic features include diffuse/nodular hypo-/marked hypoechoic lesions with internal linear hyperechoic strands, posterior acoustic enhancement, abundant vascularity, and absence of calcification. When PTL is clinically suspected, CNB cytology examination is recommended as the preferred method to improve diagnostic accuracy. Comprehensive treatment based on immunochemotherapy with or without radiotherapy can provide a favorable prognosis.
| [1] | JIN S, XIE L, YOU Y, et al. Development and validation of a nomogram to predict B-cell primary thyroid malignant lymphoma-specific survival: A population-based analysis[J]. Front Endocrinol (Lausanne), 2022, 13:965448. |
| [2] | OTA H, ITO Y, MATSUZUKA F, et al. Usefulness of ultrasonography for diagnosis of malignant lymphoma of the thyroid[J]. Thyroid, 2006, 16(10):983-987. |
| [3] | SWERDLOW S H, CAMPO E, PILERI S A, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J]. Blood, 2016, 127(20):2375-2390. |
| [4] | CHESON B D, FISHER R I, BARRINGTON S F, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification[J]. J Clin Oncol, 2014, 32(27):3059-3068. |
| [5] | ZIEPERT M, HASENCLEVER D, KUHNT E, et al. Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era[J]. J Clin Oncol, 2010, 28(14):2373-2380. |
| [6] | 中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)淋巴瘤诊疗指南2023[M]. 北京, 人民卫生出版社,2023:4. |
| Guideline Working Committee of Chinese society of clinical oncology. Guidelines of Chinese society of Clinical Oncology (CSCO) lymphoid malignancies 2023[M]. Beijing: People's Medical Publishing House,2023:4. | |
| [7] | ZHU Y, YANG S, HE X. Prognostic evaluation models for primary thyroid lymphoma, based on the SEER database and an external validation cohort[J]. J Endocrinol Invest, 2022, 45(4):815-824. |
| [8] | WATANABE N, NOH J Y, NARIMATSU H, et al. Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto's disease[J]. Br J Haematol, 2011, 153(2):236-243. |
| [9] | LIU L, YU Y, CHEN L, et al. Clinical differences between IgG4 Hashimoto's thyroiditis and primary thyroid lymphoma[J]. Eur Thyroid J, 2022, 11(3):e210144. |
| [10] | VANDER POORTEN V, GOEDSEELS N, TRIANTAFYLLOU A, et al. Effectiveness of core needle biopsy in the diagnosis of thyroid lymphoma and anaplastic thyroid carcinoma: A systematic review and meta-analysis[J]. Front Endocrinol (Lausanne), 2022, 13:971249. |
| [11] | ALEXANDER L F, PATEL N J, CASERTA M P, et al. Thyroid ultrasound: diffuse and nodular disease[J]. Radiol Clin North Am, 2020, 58(6):1041-1057. |
| [12] | PENG C, YI D, ZHOU Y, et al. Differential diagnosis of non-diffuse primary thyroid lymphoma and papillary thyroid carcinoma by ultrasound combined with computed tomography[J]. BMC Cancer, 2022, 22(1):938. |
| [13] | GU L S, CUI N Y, WANG Y, et al. Comparison of sonographic characteristics of primary thyroid lymphoma and anaplastic thyroid carcinoma[J]. J Thorac Dis, 2017, 9(11):4774-4784. |
| [14] | 杨盼, 孙映荷, 马步云, 等. 原发性甲状腺非霍奇金淋巴瘤的超声征象分析[J]. 中国普外基础与临床杂志, 2014, 21(9):1092-1096. |
| YANG P, SUN Y H, MA B Y, et al. Ultrasonography features of primary thyroid non-Hodgkin lymphoma[J]. Chin J Bases Clin General Surg, 2014, 21(9):1092-1096. | |
| [15] | MATSUZUKA F, MIYAUCHI A, KATAYAMA S, et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases[J]. Thyroid, 1993, 3(2):93-99. |
| [16] | LEE J S, SHIN S J, YUN H J, et al. Primary thyroid lymphoma: A single-center experience[J]. Front Endocrinol (Lausanne), 2023, 14:1064050. |
| [17] | WATANABE N, NARIMATSU H, NOH J Y, et al. Long-term outcomes of 107 cases of primary thyroid mucosa-associated lymphoid tissue lymphoma at a single medical institution in Japan[J]. J Clin Endocrinol Metab, 2018, 103(2):732-739. |
| [18] | 中华医学会内分泌学分会, 中华医学会外科学分会甲状腺及代谢外科学组, 中国抗癌协会头颈肿瘤专业委员会, 等. 甲状腺结节和分化型甲状腺癌诊治指南(第二版)[J]. 中华内分泌代谢杂志, 2023, 39(3):181-226. |
| Chinese Society of Endocrinology, Thyroid and Metabolism Surgery Group of the Chinese Society of Surgery, China Anti-Cancer Association, et al. Guidelines for the diagnosis and management of thyroid nodules and differentiated thyroid cancer (Second edition)[J]. Chin J Endocrinol Metab, 2023, 39(3):181-226. |
/
| 〈 |
|
〉 |